Page last updated: 2024-08-21

quinazolines and Insulin Resistance

quinazolines has been researched along with Insulin Resistance in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's3 (20.00)29.6817
2010's10 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aroor, AR; Bender, SB; Demarco, VG; Garro, M; Hayden, MR; Johnson, MS; Mugerfeld, I; Nistala, R; Salam, M; Sowers, JR; Whaley-Connell, A1
Benterki, I; Fontés, G; Peyot, ML; Poitout, V; Prentki, M; Seda, O; Zarrouki, B1
Kontani, Y; Kusudo, T; Mori, N; Okamatsu, Y; Saito, M; Takeuchi, T; Wang, T; Yamashita, H; Yamashita, Y1
Chen, ZF; Guo, WW; Li, Z; Liu, LH; Wu, GY; Xie, JY; Yi, JY; Zhang, L; Zhang, ZJ1
Chan, KC; Chen, ML; Huang, CN; Peng, CH; Wang, CJ; Yang, YS1
Bian, K; Nie, XQ; Shi, HX; Yang, JW; Yuan, Y; Zhang, JY; Zhang, YJ1
Yamashita, H1
Carvalheira, JB; Cintra, DE; de Souza, CT; Franchini, KG; Mourão, RH; Pauli, JR; Prada, PO; Rittner, R; Rocco, SA; Ropelle, ER; Saad, MJ; Schenka, A; Vassallo, J; Velloso, LA1
Arellano-Plancarte, A; Catt, KJ; Hernandez-Aranda, J; Olivares-Reyes, JA1
Li, YX; Sun, Q; Wang, H; Wang, SN1
Akanuma, M; Fujiya, M; Hiranaka, N; Ieko, M; Kanazawa, K; Kohgo, Y; Naito, S; Oka, K; Suzuki, T; Takahashi, N; Yoshida, M; Yoshizaki, T; Yui, T1
Blüher, M; Kern, M; Klein, T; Klöting, N; Mark, M; Niessen, HG; Stiller, D; Thomas, L1
Ihara, S; Kawana, M; Sakai, R; Shimamoto, K; Watanabe, H1
Hara, Y; Harano, Y; Kanazawa, A; Nishioheda, Y; Ryomoto, K; Shinozaki, K; Suzuki, M; Tsushima, M1
Asakura, Y; Harano, Y; Hirose, J; Kageyama, A; Omae, T; Sato, A; Suzuki, M1

Trials

1 trial(s) available for quinazolines and Insulin Resistance

ArticleYear
An alpha1-receptor blocker reduces plasma leptin levels in hypertensive patients with obesity and hyperleptinemia.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Body Mass Index; Delayed-Action Preparations; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Hypertension; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Quinazolines; Receptors, Leptin; Treatment Outcome

2006

Other Studies

14 other study(ies) available for quinazolines and Insulin Resistance

ArticleYear
Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.
    Endocrinology, 2013, Volume: 154, Issue:7

    Topics: Animals; Blood Pressure; Body Weight; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Eating; Insulin Resistance; Linagliptin; Male; Myocardium; Nitric Oxide Synthase Type III; Purines; Quinazolines; Rats; Rats, Zucker; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2013
Epidermal growth factor receptor signaling promotes pancreatic β-cell proliferation in response to nutrient excess in rats through mTOR and FOXM1.
    Diabetes, 2014, Volume: 63, Issue:3

    Topics: Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; ErbB Receptors; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Profiling; Insulin Resistance; Insulin-Secreting Cells; Male; Quinazolines; Rats; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Tyrphostins

2014
Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Evodia; Female; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Mice; Mice, Obese; Phosphorylation; Quinazolines; Ribosomal Protein S6 Kinases; Serine; Signal Transduction; TOR Serine-Threonine Kinases

2013
Evodiamine activates AMPK and promotes adiponectin multimerization in 3T3-L1 adipocytes.
    Journal of Asian natural products research, 2014, Volume: 16, Issue:11

    Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Animals; Calcium; Evodia; Insulin Resistance; Mice; Molecular Structure; Molecular Weight; Phosphatidylinositol 3-Kinases; Quinazolines; Signal Transduction

2014
Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.
    Journal of agricultural and food chemistry, 2014, Oct-08, Volume: 62, Issue:40

    Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Epithelial-Mesenchymal Transition; Glucose; Hibiscus; Insulin Receptor Substrate Proteins; Insulin Resistance; Kidney; Linagliptin; Male; Phosphorylation; Polyphenols; Purines; Quinazolines; Rats, Sprague-Dawley; Vimentin

2014
[Effects of rutaecarpine on inflammatory cytokines in insulin resistant primary skeletal muscle cells].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2014, Volume: 39, Issue:15

    Topics: Animals; Cell Proliferation; Cytokines; Female; Glucose; Indole Alkaloids; Inflammation; Insulin Resistance; Male; Muscle, Skeletal; Quinazolines; Rats

2014
A natural compound Evo(kes) signaling for fat regulation.
    Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:18

    Topics: Animals; Female; Insulin Receptor Substrate Proteins; Insulin Resistance; Quinazolines; Ribosomal Protein S6 Kinases; TOR Serine-Threonine Kinases

2014
EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
    Diabetes, 2009, Volume: 58, Issue:12

    Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Dietary Fats; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Enzymologic; Glucose Tolerance Test; Hypoglycemic Agents; Immunoblotting; Immunoprecipitation; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Leptin; Liver; Macrophages; Male; Mice; Muscle, Skeletal; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; Tumor Necrosis Factor-alpha

2009
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
    Biochemical pharmacology, 2010, Mar-01, Volume: 79, Issue:5

    Topics: Angiotensin II; Animals; Cell Line; Enzyme Inhibitors; ErbB Receptors; Hepatocytes; Insulin; Insulin Resistance; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptor, Insulin; Serine; Signal Transduction; Threonine; Transcriptional Activation; Tyrphostins; Vasoconstrictor Agents

2010
[Gefitinib improves insulin sensitivity in Wistar diabetes rats models].
    Zhonghua yi xue za zhi, 2009, Dec-29, Volume: 89, Issue:48

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gefitinib; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Phosphatidylinositol 3-Kinases; Quinazolines; Rats; Rats, Wistar

2009
Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes.
    Biochemical and biophysical research communications, 2011, Nov-11, Volume: 415, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Chemokine CCL2; Chemotaxis; Gene Expression; Insulin Resistance; Mice; NF-kappa B; Nuclear Proteins; Obesity; Phosphatidate Phosphatase; Protein Biosynthesis; Quinazolines; RNA, Messenger; RNA, Small Interfering; Salicylates

2011
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Adipose Tissue; Animals; Diet; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Female; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Insulin; Insulin Resistance; Linagliptin; Liver; Mice; Mice, Inbred C57BL; Obesity; Purines; Quinazolines

2012
Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1996, Volume: 19 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Cilazapril; Humans; Insulin Resistance; Middle Aged; Quinazolines

1996
Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin).
    American journal of hypertension, 1992, Volume: 5, Issue:12 Pt 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Apoproteins; Blood Glucose; Blood Pressure; Catecholamines; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Obesity; Quinazolines; Sodium

1992